Regulation of hepatic fibrosis and extracellular matrix genes by the Th response: New insight into the role of tissue inhibitors of matrix metalloproteinases

Journal of Immunology

Volumn 167, Issue 12, 2001, Pages 7017-7026

  Vaillant, B ^a   Chiaramonte, M G ^a   Cheever, A W ^a   Soloway, P D ^a   Wynn, T A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; GAMMA INTERFERON; GELATINASE A; GELATINASE B; INTERLEUKIN 10; MACROPHAGE ELASTASE; MESSENGER RNA; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; LIVER FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMIASIS; SIGNAL TRANSDUCTION;

EID: 0035892755     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.12.7017     Document Type: Article

References (67)

1. Utilization of fractionated soluble egg antigens reveals selectively modulated granulomatous and lymphokine responses during murine schistosomiasis mansoni
2. + Th2 response induced by Schistosoma mansoni eggs develops rapidly, through an early, transient, Th0-like stage
3. Down regulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth. Schistosoma mansoni
4. Down-regulation of interleukin-12, interleukin-12R expression/activity mediates the switch from Th1 to Th2 granuloma response during murine Schistosomiasis mansoni
5. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis
6. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response
7. IL-10 and the dangers of immune polarization: Excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis
8. Membrane associated matrix metalloproteinases in metastasis
9. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling
10. Matrix metalloproteinases in inflammatory demyelination: Targets for treatment
11. Myocardial matrix degradation and metalloproteinase activation in the failing heart: A potential therapeutic target
12. Expression and localization of matrix metalloproteinase-12 in the aorta of cholesterol-fed rabbits: Relationship to lesion development
13. Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase
14. Matrix metalloproteinases
15. Murine tissue inhibitor of metalloproteinases-4 (Timp4): cDNA isolation and expression in adult mouse tissues
16. Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP-4)
17. Tissue inhibitors of metalloproteinases: Evolution, structure and function
18. Tissue inhibitors of matrix metalloendopeptidases
19. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin
20. Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase. Identification of a stabilization site
21. Specific, high affinity binding of tissue inhibitor of metalloproteinases metalloprotemases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A
22. Cell surface activation of progelatinase A (proMMP-2) and cell migration
23. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells: A possible new growth factor in serum
24. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity
25. Cell growth promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2)
26. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1
27. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase
28. TIMP-2 over-expression reduces invasion and angiogenesis and protects BI6FI0 melanoma cells from apoptosis
29. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell prolferation
30. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3
31. In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1
32. Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene
33. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro
34. Targeted mutagenesis of Timp-1 reveals that lung tumor invasion is influenced by Timp-1 genotype of the tumor but not by that of the host
35. TIMP-2 is required for efficient activation of proMMP-2 in vivo
36. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni
37. An MMP-9 mutant without gelatinolytic activity as a novel TIMP-1-antagonist
38. Mechanisms and therapy of hepatic fibrosis: Report of the AASLD Single Topic Basic Research Conference
39. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model
40. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis
41. Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell I- and T helper cell 2-type cytokine responses in vivo
42. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
43. IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease
44. An IL- 12-based vaccination method for preventing fibrosis induced by schistosome infection
45. Unimpaired down-modulation of the hepatic granulomatous response in CD8 T-cell- and γ interferon-deficient mice chronically infected with Schistosoma mansoni
46. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury
47. Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response
48. Endogenous desensitization: Changing host granulomatous response to schistosome eggs at different stages of infection with Schistosoma mansoni
49. Interstitial fibrosis in mice with overload proteinuria: Deficiency of TIMP-1 is not protective
50. Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats
51. Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers
52. In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation
53. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation
54. TIMP-2 is required for efficient activation of proMMP-2 in vivo
55. Granules of the human neutrophilic polymorphonuclear leukocyte
56. Kupffer cell-derived 95-kD type IV rV collagenase/gelatinase B: Characterization and expression in cultured cells
57. Migration of eosinophils through basement membrane components in vitro: Role of matrix metalloproteinase-9
58. T cell gelatinases mediate basement membrane transmigration in vitro
59. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
60. Increased matrix metalloproteinase-9 in the airway after allergen challenge
61. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B
62. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin
63. Regulation and significance of hepatocyte-derived matrix metalloproteinases in liver remodeling
64. Complex role of matrix metalloproteinases in angiogenesis
65. A study of the vascular changes in bilharzic hepatic fibrosis and their significance
66. Hepatic vascular lesions in mice infected with Schistosoma mansoni
67. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat